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Abstract
Objective
Tendinopathy is often a disabling, and persistent musculoskeletal disorder. Psychological
factors appear to play a role in the perpetuation of symptoms and influence recovery in mus-
culoskeletal pain. To date, the impact of psychological factors on clinical outcome in tendino-
pathy remains unclear. Therefore, the purpose of this systematic review was to investigate
the strength of association between psychological factors and clinical outcome in
tendinopathy.
Methods
A systematic review of the literature and qualitative synthesis of published trials was con-
ducted. Electronic searches of ovid MEDLINE, ovid EMBASE, PsychINFO, CINAHL and
Cochrane Library was undertaken from their inception to June 2020. Eligibility criteria
included RCT’s and studies of observational design incorporating measurements of psycho-
logical factors and pain, disability and physical functional outcomes in people with tendino-
pathy. Risk of Bias was assessed by two authors using a modified version of the Newcastle
Ottawa Scale. High or low certainty evidence was examined using the GRADE criteria.
Results
Ten studies of observational design (6-cross sectional and 4 prospective studies), involving
a sample of 719 participants with tendinopathy were included. Risk of bias for the included
studies ranged from 12/21 to 21/21. Cross-sectional studies of low to very low level of cer-
tainty evidence revealed significant weak to moderate strength of association (r = 0.24 to
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0.53) between psychological factors and clinical outcomes. Prospective baseline data of
very low certainty evidence showed weak strength of association between psychological
factors and clinical outcome. However, prospective studies were inconsistent in showing a
predictive relationship between baseline psychological factors on long-term outcome. Cross
sectional studies report similar strengths of association between psychological factors and
clinical outcomes in tendinopathy to those found in other musculoskeletal conditions.
Conclusion
The overall body of the evidence after applying the GRADE criteria was low to very low cer-
tainty evidence, due to risk of bias, imprecision and indirectness found across included stud-
ies. Future, high quality longitudinal cohort studies are required to investigate the predictive
value of baseline psychological factors on long-term clinical outcome.
Introduction
Tendinopathy, previously referred to as tendinitis or tendinosis, is a common musculoskeletal
(MSK) condition characterised clinically by pain reported around the affected tendon with
loading [1]. Tendinopathy affects both athletic and non-athlectic populations alike. For exam-
ple, Achilles tendinopathy is reported in up to 50% of runners before the age of 45 years [2]. In
a Dutch general practice, Albers et al. [3] reported lower extremity tendinopathy prevalence
rates of 11.8 per 1000 person-years, whilst prevalence rates for upper limb tendinopathies have
been estimated between 1.3% to 21.0% [4–6].
Recommended care for tendinopathy includes progressive exercise interventions such as
heavy-slow resistance (HSR), concentric and/or eccentric strengthening [7,8]. Success rates
reported using such exercise programmes in Achilles tendinopathy have been shown to vary
between 56% and 100%. [9,10] whilst moderate response rates of 41% have been reported for
eccentric exercise in people with lateral elbow tendinopathy [11]. Given the often persistent
and multifactorial nature of tendinopathy, similar to to other MSK disorders, treatments in
tendinopathy may need to address the multiple factors that contribute to pain, dysfunction
and disability experienced.
It has been suggested that psychological factors such as fear of reinjury, pain catastrophis-
ing, external locus of control and low self efficacy may negatively impact on clinical outcomes
in common musculoskeletal disorders [12–15]. However, to date, the contribution of psycho-
logical factors to the pain, dysfunction and disability experienced in tendinopathy and the ben-
efits of focussing upon theses factors as treatment targets remain uncertain. Recent qualitative
studies have outlined the negative psychological impact of persistent Achilles tendinopathy,
rotator cuff tendinopathy and greater trochanteric pain syndrome [16–19]. Likewise, a recent
cross-sectional study reported greater levels of psychological distress and poorer quality of life
among patients with more severe gluteal tendinopathy [20].
Previous systematic reviews [21,22] concluded that there was a conflicting evidence-base
for the association of psychological factors and clinical outcome in people with tendinopathy.
Several factors have been highlighted as potential explanations for the conflicting evidence
base, such as, variance in population, heterogeneity of outcome measures and differing cogni-
tive factors [21,22]. Despite the ambiguity, previous reviews suggest specific psychological vari-
ables may be associated with tendinopathy and suboptimal outcomes. Interestingly, no data
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has yet been provided regarding the strength of association of psychological factors and out-
come in people with tendinopathy and how they compare with other common MSK condi-
tions. If psychological factors were shown to be strongly associated with pain, disability and
physical functional outcomes, and if trials of management approaches that focus on these fac-
tors show them to be beneficial, it would provide stronger justification for targeting these fac-
tors in real-life management [21]. To address this, we aimed to identify and synthesise
available evidence investigating the strength of association between psychological factors and
clinical outcomes in tendinopathy.
Methods
Protocol details were registered in the international prospective register of systematic reviews
(PROSPERO—registration number CRD42019139757) and reported in accordance with the
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) [23].
Eligibility criteria
Studies investigating a relationship between (i) psychological domains and (ii) clinical mea-
sures of pain and/or disability/function in tendinopathy were deemed suitable for inclusion.
Randomised controlled trials (RCTs), quasi-experimental studies, cross-sectional uncontrolled
trials, case-control, case series and cohort studies were eligible. Reviews, case studies, editori-
als, and studies with between group analysis were excluded.
Participants
Studies which included adult participants labelled as having a tendinopathy of any duration,
affecting the upper (rotator cuff, lateral elbow tendinopathy) or lower limb (plantar heel pain,
Achilles tendinopathy, patellar tendinopathy, gluteal trochanteric pain syndrome), were
included. In keeping with recent recommendations tendinopathy diagnosis could be based on
clinical history and assessment, excluding other potential diagnosis, with or without imaging.
Outcome measures
Psychological outcomes. Self-reported psychological instruments commonly reported in
musculoskeletal literature measuring the following psychological factors were deemed suitable
for inclusion in the review [24–26].
• Emotional factors including, but not limited to, depression, distress, anxiety, hypervigi-
lance/somatisation, stress and anger.
• Cognitive factors including, but not limited to, maladaptive beliefs, fear, kinesiophobia, cat-
astrophising, negative pain beliefs, self-efficacy.
• Behavioural factors including but not limited to avoidance, maladaptive (negative coping
-styles.
Clinical outcomes. An a-priori decision was made to include the following clinical
parameters relating to pain and disability as secondary outcomes: objective physical function,
pain, self-reported disability, and any adverse effects.
• Objective physical function: Including but not limited to strength (isometric, isotonic,
endurance), heel raise test, hop, balance and jumping tests.
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• Self-reported disability: The data were extracted from the function scale highest on the fol-
lowing tendinopathy function scale hierarchy when trialists reported data for more than one
scale.
• Victorian Institute of Sports Assessment (VISA-P VISA-A, VISA-G).
• Any other tendon specific disability scale (Shoulder Pan and Disability Index SPADI),
• Global Rating of Change (GROC)
• Pain–Including, but not limited to, pain severity, overall pain, daily pain, pain with activity—
including mean pain or change in mean overall pain measured via visual analogue scale
(VAS), numerical rating scale (NRS) or categorical scale.
• Adverse effects: Number of participants experiencing an adverse effect (as defined by the
trial authors)
Timing of outcome assessment
Psychological and clinical outcomes were extracted and categorised into timelines. The follow-
ing timelines were established, a priori, based upon previous literature [27,28]:
• Up to 4-weeks
• > 4-weeks and up to 3-months
• > 3-months
Data sources and search
A systematic search of the following databases was performed by the lead author (CS): ovid
MEDLINE, PsychINFO, Cochrane Library, ovid EMBASE and CINAHL plus. The search was
originally performed in May 2019 and updated in June 2020. A sensitive search strategy using
relevant search terms was developed from Medical Subject Headings (MeSH) and keywords
were used (see Table 1). The complete search strategy for each database is shown in Appendix
1. Relevant grey literature was also searched via OpenGrey and ongoing trials via the National
Institute of Health (clinicaltrials.gov). The electronic search was supplemented by hand search-
ing of references lists from included articles.
Selection of studies
Database screening was conducted by one author (CS) who screened titles and abstracts for
potentially eligible trials based on predetermined criteria. Any potentially eligible studies along
Table 1. Keywords used in the search strategy.
Main search terms
1. Tendinitis or tendinopathy or epicondylitis or tennis elbow or shoulder impingement syndrome or rotator cuff
injury or jumper’s knee (MESH)
2. Fear or depression or anxiety or catastrophizing or coping behaviour or avoidance behaviour or emotion or self-
efficacy (MeSH)
3. 1 and 2 combined
https://doi.org/10.1371/journal.pone.0242568.t001
PLOS ONE The strength of association between psychological factors and clinical outcome in tendinopathy
PLOS ONE | https://doi.org/10.1371/journal.pone.0242568 November 30, 2020 4 / 23
with studies whose abstract did not provide enough information, were retrieved for full-text
review and independently assessed by two authors (CS & AM) to determine eligibility. In cases
of disagreement an agreement was made by consensus, and if required a third author was con-
sulted (PM).
Data extraction
Two authors (CS & PM) independently extracted data from each study to a standardised form.
Disagreements were resolved through consensus, or through a third reviewer (SM) if required.
The following data were extracted from each study where available (see Table 2):
• Study characteristics (first author, year of publication, study design [e.g. case control], coun-
try, source of funding, sample size, trial registration [If registration number is reported]).
• Patient characteristics (mean age, mean duration of symptoms, sex, educational status, phys-
ical activity status, work status).
• Outcomes (psychological measures, function, disability, pain intensity, adverse events–as
detailed above).
Risk of bias and overall certainty
Two reviewers (CS & AM) independently assessed the risk of bias of each individual study
using the Newcastle-Ottawa Scale (NOS) see Table 3. The NOS is a review tool for evaluating
risk of bias in non-randomised studies [39,40]. An adapted version of the scale was selected to
evaluate all studies because many were single cohort cross-sectional observational studies
[41,42]. The tool consists of four domains of risk of bias assessment; (i) selection bias; (ii) per-
formance bias; (iii) detection bias and; (iv) information bias. Seven items assess the four
domains and each item is scored from zero (high risk) to three (low risk), with a total maxi-
mum score of 21 points. We then rated the overall risk of bias in each study as high (0–6),
moderate (7–13), or low (14–21) in line with previous studies [39,40].
The overall certainty of the evidence was assessed by two teams of researchers (CS with
either PM or SM) using the Grading of Recommendations Assessment, Development and
Evaluation (GRADE) approach (see Table 4). The GRADE system classifies the certainty of
evidence into four levels; high (further research is very unlikely to change our confidence);
moderate (further research is likely to have an impact on our confidence); low (further
research is very likely to have an important impact on our confidence); and very low (any esti-
mate effect is very uncertain) [43].
The certainty of evidence is based upon five criteria (risk of bias, imprecision, inconsis-
tency, indirectness and publication bias). As all eligible studies were observational designs, all
studies started with a ‘low quality’ rating. Grading upwards was warranted if: 1) a large magni-
tude of effect existed; 2) there was a dose-response gradient, and 3) all plausible confounders
and other biases increased our confidence of estimated effect [44].
Data synthesis
Due to the heterogeneity of the included studies regarding body site, psychological domains,
interventions, outcome measures and study design we were unable to pool data from individ-
ual studies to perform a meta-analysis. Qualitative synthesis was undertaken with studies
grouped specific to each tendon site. Where possible, confidence intervals were calculated
from Pearson’s r effect sizes and unstandardised and standardised β values from individual
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studies. Pearson’s r values between 0–0.2 very weak correlation; 0.2–0.5 weak correlation; 0.5–
0.7 moderate correlation; and >0.7 strong correlation [45]. We calculated CI’s for Pearson’s r
correlation coefficients using R Core team) [46,47].
Results
Study selection
4,155 studies were identified through searching electronic databases and 3 studies were identi-
fied from additional sources. We screened 3,562 titles and abstracts after removing duplicates
and identified 44 for full-text review. A total of 10 observational studies (6-cross sectional and
4 prospective studies [3-cohort and 1-case series]) satisfied our eligibility criteria and were
included in the final review. Fig 1 illustrates the selection process. We did not find any RCT’s
or quasi-experimental interventional studies in tendinopathy that had an intervention
focussed on psychological factors.
Table 3. Risk of bias (Newcastle Ottawa Scale- modified version).
Selection bias Performance Bias Detection Bias Information bias
First Author A B C D E F G TOTAL Level of bias
Akyol et al. 2013 [29] 2 0 0 3 3 3 3 14/21 Low
Coombes et al. 2015 [30] 3 1 1 3 3 3 3 17/21 Low
Cotchett et al. 2015 [31] 3 3 2 3 3 3 0 16/21 Low
Cotchett et al. 2017 [32] 3 1 2 3 3 3 0 14/21 Low
Engebretsen et al. 2010 [33] 2 3 2 3 3 1 1 15/21 Low
Ferrer-Pena et al. 2019 [34] 2 3 0 2 3 3 3 14/21 Low
Harutaichun et al. 2019 [35] 3 3 3 3 3 3 3 21/21 Low
Kromer et al. 2014 [36] 3 3 2 3 3 3 0 16/21 Low
Maestroni et al. 2020 [37] 2 3 3 3 3 0 3 14/21 Low
Silbernagel et al. 2010 [38] 3 0 0 3 0 3 3 12/21 Moderate
A. Is the source population representative? B. Is the sample size adequate and is there sufficient power? C. Did the study adjust for confounders? D. Did the study use
appropriate statistics to measure outcome of interest? E. Is there little missing data and was it handled appropriately? F. Are the methods of outcome measurements
Explicitly stated and it is appropriate? G. Is there an objective assessment of outcomes?
https://doi.org/10.1371/journal.pone.0242568.t003
Table 4. Summary of findings and quality of evidence assessment (GRADE).
Outcome by
tendon
No. of studies Types of studies No. of
participants
Risk of
bias
Inconsistency Indirectness Imprecision Publication
bias
Level of
certainty
Rotator Cuff related
Shoulder pain
4-studies
[29,33,36,37]
3 x cross- sectional 1 x
cross-sectional
longitudinal
402 Serious
(-1)
No No No Undetected low-level
evidence
Plantar Heel Pain 3-studies
[31,32,35]
2 x cross-sectional 1 x
cohort prognostic
study
191 Serious
(-1)
No No Serious (-1) Undetected Very low-
level
evidence
Lateral Elbow
Tendinopathy
1- study [30] 1 x cohort prognostic
study
41 Serious
(-1)
No No No Undetected low-level
evidence
Greater
Trochanteric Pain
Syndrome
1-study [34] Cross sectional 51 Serious
(-1)
No Serious (-1) Serious (-1) Undetected Very low-
level
evidence
Achilles Tendon 1-study [38] Case Series 34 Serious
(-1)
No No Serious (-1) Undetected Very low-
level
evidence
https://doi.org/10.1371/journal.pone.0242568.t004
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Characteristics of included studies
A total of 719 participants (49.1% females) with tendinopathy were included in the eligible
studies. The mean age of participants across the included studies was 48 years of age with a
mean duration of symptoms of 14.5 months. Four studies investigated rotator cuff related
shoulder pain (subacromial impingement syndrome, subacromial shoulder pain, rotator cuff
related shoulder pain) [29,33,36,37], three investigated plantar heel pain [31,32,35], one inves-
tigated lateral elbow tendinopathy [31], one investigated greater trochanteric pain syndrome
[34] and the remaining study by Silbernagel et al. [38], investigated Achilles tendinopathy (see
Table 2).
Outcome measures
The outcome measures utilised across the 10 included studies are detailed in Table 2. For
psychological factors, twelve-separate psychological outcome measures were used to assess a
variety of emotional (5 outcome measures, Beck Depression Inventory (BDI), Hospital Anxi-
ety and Depression Scale (HADS), Depression Anxiety Stress Scales (DASS), Hopkins Symp-
tom Checklist-25 (HSCL-25), Outcome Evaluation Questionnaire (OEQ)) and cognitive
Fig 1. PRISMA flow diagram. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred
Reporting Items of Systematic Reviews and Analyses: The PRISMA Statement. Plos Med 6(7): e1000097. doi:10.1371/
journal.pmed1000097 For more information, visit www.prisma-statement.org.
https://doi.org/10.1371/journal.pone.0242568.g001
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(7 outcome measures, Tampa Scale of Kinesiophobia-17 (TSK-17), Tampa Scale of Kinesio-
phobia -11 (TSK-11), Tampa Scale of kinesiophobia Swedish Version -17 (TSK-SV-17),
Patient Catastrophising Scale (PCS), Chronic Pain Self-Efficacy Scale (CPSS), Fear Avoidance
Belief Questionnaire (FABQ), Patient and Impairment Relationship Scale (PAIRS)) domains.
The most common emotional factors measured were depression (6 studies, 5 separate outcome
measures) and anxiety (5 studies, 4 separate outcome measures). The most common cognitive
factor measured was kinesiophobia (4 studies, 3 outcome measures), see Table 2.
For the secondary outcomes, 10 studies included 6 separate outcome measures for pain
with pain intensity using the visual analogue scale being the most frequent (3 studies). Objec-
tive physical function was measured in 7 studies and utilising 10 separate outcome measures,
including isometric and isokinetic strength, balance, jumping and hopping. Finally, 7 studies
used 5 separate outcome measures for self-reported disability, all of which were region-spe-
cific. No studies reported adverse effects which is not surprising given none were trials.
Risk of bias
The overall risk of bias for 9/10 studies was low whilst one study was considered to be at mod-
erate risk of bias. Scores ranged from 12/21 to 21/21 (see Table 3). The most common sources
of bias were; not adjusting for confounders, (81.8%), inadequate sample size and statistical
power (54.5%) and a lack of objective outcome assessment (45.6%).
Overall certainty of evidence
Due to heterogeneity regarding tendon sites, psychological variables and outcome measures
investigated, we were unable to apply the GRADE criteria to measure the certainty of evidence
for each individual patient outcome. Consequently, the GRADE criteria was used to establish
the certainty of association as it was intended and this was also equivalent to each individual
study. Overall, the GRADE criteria demonstrated low to very low levels of certainty (see
Table 4). Limitations mostly related to risk of bias (80%), imprecision (40%) and indirectness
(10%). Observational studies included in our review had a greater potential for risk of bias due
to a lack of randomisation which increases the possibility of confounding, and selection bias
[48]. When considering imprecision, we rated down the evidence quality in four of our studies
due to the lack of reporting of 95% confidence intervals.
Associations between psychological factors and clinical outcomes
The specific associations investigated for each study are detailed in Table 2. Some representa-
tive examples are provided for each tendinopathy/tendon region below.
Rotator cuff tendinopathy
There was low certainty evidence from one study of prospective design [36] supporting a weak
positive baseline association between catastrophizing and pain (r = 0.32, p<0.01) and disability
(r = 0.37, p<0.01). Fear avoidance beliefs measured at baseline appeared to be significantly
associated with baseline disability (r = 0.237, p<0.05) but not significant with disability change
scores after 3-months.
There was low certainty evidence from three cross-sectional studies supporting a weak posi-
tive association between baseline psychological factors (including depression, anxiety and
emotional distress) and pain [33,37], disability [33,37] and a negative association with physical
function [29]. Thirty four percent (10/29) of the associations investigated were not significant,
(refer to Table 2) with some associations differing between clinical outcomes. For example,
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Kromer et al. [36] showed fear avoidance behaviour was weakly associated with baseline dis-
ability but not pain intensity. Furthermore, preliminary cross-sectional associations found
between psychological factors and disability were not always evident when confounding vari-
ables were considered using multivariate regression models [33] or when measured at long-
term follow up [36].
Plantar heel pain
Very low-level certainty evidence from a prospective cohort study found a weak positive asso-
ciation between pain intensity and both depression, (r = 0.27 (95% CI = 0.02 to 0.45) p<0.03
and stress (r = 0.27 (95% CI = 0.04 to 0.47 p<0.03) among men with plantar heel pain [35].
Two cross sectional studies demonstrated a weak to moderate association between psychologi-
cal factors (kinesiophobia, catastrophizing, depression and stress) and foot function and pain
[31,32]. Forty seven percent (16/34) of associations investigated were not significant (refer to
Table 2). Once again, the associations between clinical and psychological factors varied
between studies. For example, cross sectional analysis revealed anxiety was not significantly
associated with foot pain [31], whereas, a recent prospective cohort study showed anxiety to be
the strongest predictor of pain intensity in people with plantar heel pain (β = 0.41, p = 0.01)
[35].
Lateral elbow tendinopathy
Low certainty evidence from one cohort prognostic study suggested psychological factors
(depression and kinesiophobia) were not significantly associated with either pain or disability
in patients with lateral elbow tendinopathy at 2 or 12-months [30].
Greater trochanteric pain syndrome
Very low certainty evidence from one cross-sectional study investigated the relationship of
psychological factors (including kinesiophobia, self-efficacy and catastrophizing) and objective
physical function (dynamic balance) [34]. Those with higher catastrophising (helplessness
component) were negatively associated with poor performance in components of the Y-bal-
ance Test (r = -0.304 (95% CI = -0.53 to—0.03) p<0.05) whilst greater self-efficacy (pain com-
ponent) revealed a weak positive association with the anterior component of the Y-Balance
Test (r = 0.432 (95% CI = 0.18 to 0.62) p<0.01). Multiple linear regression analysis revealed
greater kinesiophobia, along with higher pain and poorer WOMAC total score, contributed to
a poorer score on the anterior component of the Y-Balance Test.
Achilles tendinopathy
There was very low certainty of evidence from a 5-year prospective case series by Silbernagel
et al. [38] showing a significant moderate correlation between the level of kinesiophobia (fear
of movement), and performance in a repeated standard heel raise functional test (r = -0.590
(95% CI = -0.80 to -0.2 p<0.005).
Discussion
This systematic review investigated the relationship between psychological variables and clini-
cal outcomes in tendinopathy. Ten observational studies were included, including six cross-
sectional and four prospective studies. Among the cross-sectional studies, there was low to
very low certainty evidence for an association between emotional (e.g. stress, depression) and
cognitive (e.g. kinesiophobia, fear-avoidance) issues and greater self-reported pain and
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disability as well as impaired physical function in people with tendinopathy. In addition, there
was low to very low certainty evidence for an association between higher levels of self-efficacy
and lower levels of pain intensity. In the context of our review the GRADE evaluation suggests
we have low to very low certainty in the associations identified in this review due to factors
such as risk of bias, imprecision and indirectness, hence we have very little confidence in the
effect estimate [43]. Four prospective studies revealed a conflicting association between psy-
chological factors and change in clinical outcomes. This is a key limitation of this literature,
prospective studies are required to explore cause and effect relationships [49].
The strength of association in the cross-sectional data (r = 0.24 to 0.53) is comparable to
other reviews among people with other musculoskeletal conditions [50–52]. In a review of 118
cross-sectional studies in low back pain, Kroska et al. [51] reported very weaktomoderate posi-
tive associations between fear-avoidance and pain (r = 0.01 to 0.65). Whilst, Luque-Suarez
et al. [52] included 50 cross sectional studies in their review and reported very weak to moder-
ate strength of association between kinesiophobia and pain in people with an array of different
chronic musculoskeletal pain conditions (r = 0.03 to 0.58). Taken together with findings of the
current review, psychological factors and clinical outcomes appear to share a modest associa-
tion for people with musculoskeletalal conditions. This suggests, that at least for some people
with musculoskeletal conditions, psychological factors are associated with clinical outcome,
and worthy of consideration. For example, some people may have low fear avoidance but high
pain ratings, and the reverse may also be true. Identifying people for whom psychological fac-
tors relate to pain, disability and functional outcomes may be important for a more targeted
management approach.
In contrast to cross-sectional studies, longitudinal studies can evaluate whether psychologi-
cal factors predict disease outcome over time. Studies of prediction require prospectively col-
lected longitudinal data where the outcome is not present at enrolment [53]. This temporal
sequence is important in determining cause and effect [54]. The data from the four longitudi-
nal studies were inconsistent for the predictive value of psychological factors on long term clin-
ical outcome [30,35,36,38]. This may in part be explained by methodological heterogeneity
including variability in tendon sites (4 sites), psychological factors measured (6 factors), clini-
cal outcomes assessed (7 outcomes), and assessment periods (0–60 months).
It is also noteworthy that many people in the included trials had low baseline scores for the
psychological constructs assessed. People with low baseline psychological scores may be less
likely to display a relationship between their psychological status and clinical outcomes [55].
For example, baseline mean values for kinesiophobia (TSK) were reported as 23.7 points by
Coombes et al. [30]; scores between 17–37 points are considered moderate risk of poor out-
come [56,57]. In the same study, participants recorded mean scores of 7.6 out of a total of 42
on the Hospital Anxiety and Depression Score (HADS), on which a score of 7 points (or
lower) is considered not anxious or depressed [58]. Similarly, median baseline catastrophising
was reported as 9 points by Kromer et al. [36], whereas scores>30 points are considered clini-
cally relevant [59]. As higher levels of psychological factors at baseline may predict poorer clin-
ical outcomes [57,60], it appears this population may simply be underrepresented in the
included studies; perhaps due to sampling bias or strict inclusion/exclusion criteria which
often excludes participants with high levels of pain or bilateral pain symptoms [33,36,37].
Similarly to a prior review [21], we found substantial heterogeneity in relation to the range
of psychological outcome measures across the included studies included in our review. For
instance, depression and anxiety was measured in six studies, in which six different outcome
measures were used. This lack of concensus restricts the synthesis and pooling of data for
meta-analysis.
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In accordance with other reviews [50,51,61,62] there was consistency found in instruments
used to measure fear avoidance (FABQ and kinesiophobia (TSK). Whilst the contributing role
of fear avoidance behaviours has been well established in the development of chronic lower
back pain and other musculoskeletal disorders [51,63,64], historically, this relationship has not
been adequately examined in tendinopathy studies. Hence, it is possible that people with tendi-
nopathy may not experience the same magnitude of fear and subsequent avoidance as do peo-
ple with other musculoskeletal conditions, thus, these instruments may not adequately capture
the lived experience of people with this musculoskeletal condition.
Strengths and weaknesses
Strengths of the review include pre-registering the protocol, a rigorous search strategy com-
bined with using validated methods for evaluating risk of bias and the level of evidence. The
review has been reported in accordance with PRISMA guidelines [23] and utilised two review-
ers to screen and extract data. The main limitations relate to the literature. Most studies were
cross-sectional with small samples, which are more prone to bias and confounding than pro-
spective studies, and are unable to identify temporal relationships that may be causal. Second,
high levels of heterogeneity prevented meta-analysis and limited comparisons between studies.
Finally, detailed descriptive statistics were not always available, making the task of summaris-
ing these studies consistently challenging.
Future directions
First, there is a clear need for robust longitudinal studies to investigate the predictive value of
psychological factors among people with tendinopathy. Second, significant heterogeneity of
psychological outcome measures exist in selected studies, resulting in inconsistency of report-
ing and thus preventing meta-analysis of the data; This lack of standardisation of outcome
measures limits the usefulness of clinical trial evidence [65]. Within rheumatology, this prob-
lem has been addressed through the implementation of the Outcome Measures Rheumatology
initiative (OMERACT), which has markedly improved outcome measurement for many rheu-
matologic conditions. This has been achieved by developing widely endorsed “core outcome
measurement sets” (COMS) that are to be reported in all RCT and longitudinal studies
[65,66]. Recently, the International Scientific Tendinopathy Symposium Consensus (ICON)
group have identified nine health related core domains, one being psychological factors [67].
Future studies are required to establish which psychological instruments would be applicable
to use in the chosen setting. However, first we need to determine the specific psychological
constructs that should be measured among people with tendinopathy and establish whether
currently available instruments are suitable and fit for purpose. Finally, future validation stud-
ies are required to determine how many people have clinically meaningful psychological fac-
tors in tendinopathy and identify appropriate cutoff levels for currently used instruments.
Proposed cut-off values have been established for the FABQ [68] and TSK [55] for LBP, how-
ever, none currently exist in tendinopathy. Identifying individuals who may be at low, moder-
ate or high risk of poor outcome would allow clinicians to adapt their management strategies
accordingly.
Conclusion
Synthesis of the cross-sectional data revealed low to very low certainty of evidence suggesting
weak to moderate strength of association between psychological factors and pain, disability
and physical functional outcome in tendinopathy. Importantly, data derived from cross-sec-
tional studies reported similar strengths of association to those found in other common
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musculoskeletal conditions, such as low back pain. Scarce and conflicting longitudinal data
failed to show a predictive relationship between baseline psychological factors and long-term
outcome. Hence, larger longitudinal cohort studies are required to investigate the predictive
value of psychological factors upon long-term clinical outcome in tendinopathy populations,
ensuring studies include people with meaningful levels of pain and psychological distress.
Additionally, less heterogeneity of psychological outcome measures used in tendinopathy
research is required; the development of a tendon specific measure may assist with this.
Appendix 1
Database(s): Embase Classic+Embase 1947 to 2020 July 02
Search Strategy:
# Searches Results
1 exp tendinitis/ 18220
2 tendinitis.tw. 3270
3 tend?nopath$.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
5813
4 exp achilles tendinitis/ 1535
5 achilles tend?n$.tw. 11668
6 paratenonitis.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
82
7 peritend?n$.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
943
8 jumpers knee.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
327
9 exp epicondylitis/ 4048
10 epicondyl$.tw. 5600
11 exp tennis elbow/ 2966
12 tennis elbow.tw. 1282
13 lateral epicondyl$.mp. [mp = title, abstract, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading
word, candidate term word]
2356
14 exp shoulder impingement syndrome/ 2830
15 shoulder impingement syndrom$.tw. 430
16 exp rotator cuff injury/ 11643
17 rotator cuff injur$.tw. 527
18 rotator cuff disease.mp. [mp = title, abstract, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading
word, candidate term word]
602
19 greater trochanteric pain syndrom$.mp. [mp = title, abstract, heading word, drug trade
name, original title, device manufacturer, drug manufacturer, device trade name, keyword,
floating subheading word, candidate term word]
291
20 exp fear/ 274006
21 fear$.tw. 114290
22 depression.tw. 474458
23 exp anxiety/ 219742
24 anxiety.tw. 277800
25 exp catastrophizing/ 3552
26 exp coping behavior/ 64568
(Continued )
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(Continued)
# Searches Results
27 coping behavio$.tw. 2499
28 exp avoidance behavior/ 36185
29 avoidance behavi$.tw. 5463
30 exp avoidance behavior/ 36185
31 avoidance behavi$.tw. 5463
32 (fear adj1 avoidance).mp. [mp = title, abstract, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading
word, candidate term word]
1787
33 (psycholog$ adj1 distress).mp. [mp = title, abstract, heading word, drug trade name, original
title, device manufacturer, drug manufacturer, device trade name, keyword, floating
subheading word, candidate term word]
25744
34 kinesiophobia.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
1258
35 hypervigilance.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
1063
36 catastrophi?ation.tw. 195
37 catastrophi?ing.mp. [mp = title, abstract, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading
word, candidate term word]
5704
38 exp depression/ 483960
39 exp emotion/ 619158
40 emotion$.tw. 271747
41 psycholog$.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
1097787
42 tend?nosis.mp. [mp = title, abstract, heading word, drug trade name, original title, device
manufacturer, drug manufacturer, device trade name, keyword, floating subheading word,
candidate term word]
1396
43 subacromial pain.mp. [mp = title, abstract, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading
word, candidate term word]
160
44 self efficacy.mp. 33977
45 exp plantar fasciitis/ 1689
46 plantar heel pain.mp. [mp = title, abstract, heading word, drug trade name, original title,
device manufacturer, drug manufacturer, device trade name, keyword, floating subheading
word, candidate term word]
295
47 exp physiological stress/ or exp stress/ 337643
48 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or
19 or 42 or 43 or 45 or 46
48811
49 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or
36 or 37 or 38 or 39 or 40 or 41 or 44 or 47
2348181
50 48 and 49 1380
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